Works matching IS 03407004 AND DT 2013 AND VI 62 AND IP 6

Results: 15

Elevated level of peripheral CD8CD28 T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 6, p. 1123, doi. 10.1007/s00262-013-1424-8

By:

Song, Guohong;
Wang, Xiaoli;
Jia, Jun;
Yuan, Yanhua;
Wan, Fengling;
Zhou, Xinna;
Yang, Huabing;
Ren, Jun;
Gu, Jiezhun;
Lyerly, Herbert

Publication type:

Article

Long-term survival after adoptive bone marrow T cell therapy of advanced metastasized breast cancer: follow-up analysis of a clinical pilot trial.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 6, p. 1053, doi. 10.1007/s00262-013-1414-x

By:

Domschke, Christoph;
Ge, Yingzi;
Bernhardt, Isa;
Schott, Sarah;
Keim, Sophia;
Juenger, Simone;
Bucur, Mariana;
Mayer, Luisa;
Blumenstein, Maria;
Rom, Joachim;
Heil, Joerg;
Sohn, Christof;
Schneeweiss, Andreas;
Beckhove, Philipp;
Schuetz, Florian

Publication type:

Article

Highlights of melanoma research presented at the 48th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL, June 1-5, 2012.

Published in:

2013

By:

Herlyn, Dorothee;
Krepler, Clemens

Publication type:

Report

Preexisting antitumor immunity augments the antitumor effects of chemotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 6, p. 1061, doi. 10.1007/s00262-013-1417-7

By:

Zhang, Lingbing;
Feng, Dongdong;
Yu, Lynda;
Tsung, Kangla;
Norton, Jeffrey

Publication type:

Article

A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 6, p. 1041, doi. 10.1007/s00262-013-1415-9

By:

Fenoglio, Daniela;
Traverso, Paolo;
Parodi, Alessia;
Tomasello, Laura;
Negrini, Simone;
Kalli, Francesca;
Battaglia, Florinda;
Ferrera, Francesca;
Sciallero, Stefania;
Murdaca, Giuseppe;
Setti, Maurizio;
Sobrero, Alberto;
Boccardo, Francesco;
Cittadini, Giuseppe;
Puppo, Francesco;
Criscuolo, Domenico;
Carmignani, Giorgio;
Indiveri, Francesco;
Filaci, Gilberto

Publication type:

Article

Antibody-peptide-MHC fusion conjugates target non-cognate T cells to kill tumour cells.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 6, p. 1093, doi. 10.1007/s00262-013-1408-8

By:

King, Ben;
Hamblin, Angela;
Savage, Philip;
Douglas, Leon;
Hansen, Ted;
French, Ruth;
Johnson, Peter;
Glennie, Martin

Publication type:

Article

BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 6, p. 983, doi. 10.1007/s00262-013-1405-y

By:

Sanchez-Perez, Luis;
Choi, Bryan;
Reap, Elizabeth;
Sayour, Elias;
Norberg, Pamela;
Schmittling, Robert;
Archer, Gerald;
Herndon, James;
Mitchell, Duane;
Heimberger, Amy;
Bigner, Darell;
Sampson, John

Publication type:

Article

Impaired migration of IgA-secreting cells to colon adenocarcinomas.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 6, p. 989, doi. 10.1007/s00262-013-1410-1

By:

Muthuswamy, Rangarajan;
Sundström, Patrik;
Börjesson, Lars;
Gustavsson, Bengt;
Quiding-Järbrink, Marianne

Publication type:

Article

Vaccination with anti-idiotype antibody ganglidiomab mediates a GD-specific anti-neuroblastoma immune response.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 6, p. 999, doi. 10.1007/s00262-013-1413-y

By:

Lode, Holger;
Schmidt, Manuela;
Seidel, Diana;
Huebener, Nicole;
Brackrock, Diana;
Bleeke, Matthias;
Reker, Daniel;
Brandt, Sven;
Mueller, Hans-Peter;
Helm, Christiane;
Siebert, Nikolai

Publication type:

Article

Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 6, p. 1107, doi. 10.1007/s00262-013-1425-7

By:

Mazal, Daniel;
Lo-Man, Richard;
Bay, Sylvie;
Pritsch, Otto;
Dériaud, Edith;
Ganneau, Christelle;
Medeiros, Andrea;
Ubillos, Luis;
Obal, Gonzalo;
Berois, Nora;
Bollati-Fogolin, Mariela;
Leclerc, Claude;
Osinaga, Eduardo

Publication type:

Article

Anti-tumor activity of a novel monoclonal antibody, NPC-1C, optimized for recognition of tumor antigen MUC5AC variant in preclinical models.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 6, p. 1011, doi. 10.1007/s00262-013-1420-z

By:

Patel, Sandip;
Bristol, Andrew;
Saric, Olga;
Wang, Xue-Ping;
Dubeykovskiy, Alex;
Arlen, Philip;
Morse, Michael

Publication type:

Article

Effects of interleukin-18 on natural killer cells: costimulation of activation through Fc receptors for immunoglobulin.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 6, p. 1073, doi. 10.1007/s00262-013-1403-0

By:

Srivastava, Shivani;
Pelloso, David;
Feng, Hailin;
Voiles, Larry;
Lewis, David;
Haskova, Zdenka;
Whitacre, Margaret;
Trulli, Stephen;
Chen, Yi-Jiun;
Toso, John;
Jonak, Zdenka;
Chang, Hua-Chen;
Robertson, Michael

Publication type:

Article

Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 6, p. 1083, doi. 10.1007/s00262-013-1407-9

By:

Ghansah, Tomar;
Vohra, Nasreen;
Kinney, Kathleen;
Weber, Amy;
Kodumudi, Krithika;
Springett, Gregory;
Sarnaik, Amod;
Pilon-Thomas, Shari

Publication type:

Article

Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 6, p. 1021, doi. 10.1007/s00262-013-1418-6

By:

Di Giacomo, Anna;
Calabrò, Luana;
Danielli, Riccardo;
Fonsatti, Ester;
Bertocci, Erica;
Pesce, Isabella;
Fazio, Carolina;
Cutaia, Ornella;
Giannarelli, Diana;
Miracco, Clelia;
Biagioli, Maurizio;
Altomonte, Maresa;
Maio, Michele

Publication type:

Article

The Hedgehog inhibitor cyclopamine impairs the benefits of immunotherapy with activated T and NK lymphocytes derived from patients with advanced cancer.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 6, p. 1029, doi. 10.1007/s00262-013-1419-5

By:

Onishi, Hideya;
Morisaki, Takashi;
Kiyota, Akifumi;
Koya, Norihiro;
Tanaka, Hiroto;
Umebayashi, Masayo;
Katano, Mitsuo

Publication type:

Article